 |
autologous CD4+CD25hiFoxP3+regulatory T cells |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of graft rejection following solid organ transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2013-11-19 00:00:00 |
| Sponsor | iREG Medical AB;Tallmov 2A,;Uppsala |
